Loading…
MoonLake Immunotherapeutics is projected to rise to $27.11 by 2027, a +47% move from its current price of $18.41. MLTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $17.79 | $18.40 | $19.03 | -0.04% |
| May 30 | $17.54 | $18.39 | $19.29 | -0.09% |
| May 31 | $17.35 | $18.39 | $19.49 | -0.13% |
| Jun 1 | $17.18 | $18.38 | $19.66 | -0.17% |
| Jun 2 | $17.04 | $18.37 | $19.81 | -0.21% |
| Jun 3 | $16.91 | $18.36 | $19.94 | -0.26% |
| Jun 4 | $16.79 | $18.35 | $20.06 | -0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $16.79 | $18.35 | $20.06 | -0.30% |
| Week 2 | $16.13 | $18.30 | $20.75 | -0.60% |
| Week 3 | $15.64 | $18.24 | $21.29 | -0.90% |
| Week 4 | $15.22 | $18.19 | $21.73 | -1.20% |
| Week 5 | $14.86 | $18.13 | $22.13 | -1.49% |
| Week 6 | $14.54 | $18.08 | $22.49 | -1.79% |
| Week 7 | $14.24 | $18.03 | $22.81 | -2.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis.
The company was founded in 2021 and is headquartered in Zug, Switzerland.
MoonLake Immunotherapeutics (MLTX) is a clinical-stage biotechnology company. Its current price is $18.19, and its market cap is $1.34B. It is ranked 2316.
The price outlook is reflected in the forecast path, with 2026 averaging $18.19 (NEUTRAL) and rising to higher levels in later years, including 2030 averaging $45.56 and 2050 averaging $299.56, with a bullish trajectory indicated for most years after 2026.
Forecasts imply a bullish drift across much of the forward horizon, with notable year-by-year increases in average price from 2027 ($26.11) through 2050 ($299.56). The 2026 forecast is neutral, while subsequent years carry a bullish sentiment.
A major floor 19.8% below — a decisive break under it would weaken the trend.
The nearest floor, 12.5% below — buyers have tended to step in here.
Price is pressing into resistance (2.3% away) — a breakout level to watch.
A major ceiling 11.4% above — clearing it would confirm fresh momentum.
Key MLTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $18.07 | Buy | $18.08 | Buy |
| MA 10 | $17.75 | Buy | $17.86 | Buy |
| MA 20 | $17.51 | Buy | $17.68 | Buy |
| MA 50 | $17.47 | Buy | $17.47 | Buy |
| MA 100 | $16.96 | Buy | $18.04 | Buy |
| MA 200 | $21.73 | Sell | $22.21 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.71 | Neutral |
| Stoch RSI (14) | 76.83 | Neutral |
| CCI (20) | 82.00 | Neutral |
| Williams %R (14) | -17.41 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 7.91 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 82.59 | Sell |
| TRIX (15) | 0.05 | Buy |
| Awesome (5,34) | 0.45 | Buy |
| Ultimate (7,14,28) | 58.10 | Neutral |
| Momentum (10) | 0.22 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 18.61 | Sell |
| ADX (14) | 9.46 | Neutral |
| ATR (14) | 0.53 | Info |
The 30-day technical picture is bullish. RSI14 stands at 50, with a SMA50 of $17.42 and a SMA200 of $22.06. Support is seen at $16.11 and resistance at $18.84, framing a 30-day range from $14.37 to $23.03.
Annualized volatility is 70%, highlighting elevated price movement potential over the short term. These factors together describe a momentum-leaning setup with defined near-term support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.17 | $18.41 | $25.87 | 0% | Neutral | |
| $21.02 | $27.11 | $37.32 | +47% | Bullish | |
| $24.74 | $33.03 | $47.44 | +79% | Bullish | |
| $30.75 | $42.25 | $62.75 | +130% | Bullish | |
| $34.12 | $48.11 | $73.50 | +161% | Bullish | |
| $33.41 | $48.25 | $75.54 | +162% | Bullish | |
| $38.37 | $56.66 | $90.68 | +208% | Bullish | |
| $42.35 | $63.86 | $104.25 | +247% | Bullish | |
| $52.90 | $81.39 | $135.33 | +342% | Bullish | |
| $65.54 | $102.79 | $173.83 | +458% | Bullish | |
| $84.45 | $144.76 | $262.77 | +686% | Bullish | |
| $168.21 | $337.83 | $679.19 | +17.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $11.17 | $18.41 | $21.73 | +0.00% |
| June 2026 | $15.41 | $18.19 | $22.05 | -1.20% |
| July 2026 | $14.84 | $17.70 | $21.81 | -2.68% |
| August 2026 | $15.27 | $18.37 | $22.92 | +3.75% |
| September 2026 | $15.68 | $18.98 | $23.93 | +3.34% |
| October 2026 | $15.35 | $18.70 | $23.79 | -1.49% |
| November 2026 | $15.48 | $18.96 | $24.32 | +1.41% |
| December 2026 | $16.26 | $20.02 | $25.87 | +5.57% |
Click any year to see its month-by-month MLTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MLTX could reach as high as $25.87, with a base case around $18.41 and support toward $11.17 — roughly 0% from $18.41. Price action looks broadly range-bound.
Expect MLTX to range from $21.02 to $37.32 through 2027. The $27.11 average target implies a +47% move from current prices. That is up +47% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MLTX price prediction for 2028 points to an average of $33.03 (low $24.74, high $47.44) — a potential gain of +79% on today's $18.41. Momentum favours further upside here.
In 2029, MLTX is projected to trade between $30.75 and $62.75, averaging $42.25 — a potential gain of +130% from today's $18.41. That is up +28% on the projected 2028 average. Buyers look set to stay in control over this stretch.
MoonLake Immunotherapeutics's 2030 outlook centres on $48.11, within a $34.12 to $73.50 range. That is up +14% on the projected 2029 average. That marks a +161% change versus current levels. Momentum favours further upside here.
By 2031, MLTX could reach as high as $75.54, with a base case around $48.25 and support toward $33.41 — roughly +162% from $18.41. Buyers look set to stay in control over this stretch.
Expect MLTX to range from $38.37 to $90.68 through 2032. The $56.66 average target implies a +208% move from current prices. That is up +17% on the projected 2031 average. Momentum favours further upside here.
The MLTX price prediction for 2033 points to an average of $63.86 (low $42.35, high $104.25) — a potential gain of +247% on today's $18.41. Buyers look set to stay in control over this stretch.
In 2034, MLTX is projected to trade between $52.90 and $135.33, averaging $81.39 — a potential gain of +342% from today's $18.41. That is up +27% on the projected 2033 average. Momentum favours further upside here.
MoonLake Immunotherapeutics's 2035 outlook centres on $102.79, within a $65.54 to $173.83 range. That is up +26% on the projected 2034 average. That marks a +458% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MLTX could reach as high as $262.77, with a base case around $144.76 and support toward $84.45 — roughly +686% from $18.41. Momentum favours further upside here.
Expect MLTX to range from $168.21 to $679.19 through 2050. The $337.83 average target implies a +17.4x move from current prices. That is up +133% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MLTX today (≈ 54.318305 MLTX) could be worth
$18,350.35
+$17,350.35 (+1735%) by 2050 · US Dollar
Based on the average projected MLTX price of $337.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLTXwould be worth at today's price.
$1,000 invested in MLTX on May 27, 2025 (≈ 25.920165 MLTX) would be worth
$477.19
-$522.81 (-52.3%) today · 0.48× · US Dollar
Based on a MLTX entry price of $38.58 vs. today's $18.41.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.05 | $1,079.77 | +8.0% |
| 1 month ago | $16.85 | $1,092.58 | +9.3% |
| 3 months ago | $17.68 | $1,041.29 | +4.1% |
| 6 months ago | $13.73 | $1,340.86 | +34.1% |
| 1 year ago | $38.58 | $477.19 | -52.3% |
| All time (5.0y) ago | $9.96 | $1,848.39 | +84.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLTX forecast.
Our base-case forecast reaches $37.00 around 2029.
Implied market cap at $37.00: $2.72B
The multi-year outlook shows a bullish trajectory across the horizon, with 2026 labeled as NEUTRAL and 2027 through 2050 labeled as BULLISH. In particular, the forecast highlights 2030 with an average of $45.56 and an ROI of 150.5%, 2040 with an average of $130.02 and an ROI of 614.8%, and 2050 with an average of $299.56 and an ROI of 1546.8%.
These long-range forecasts suggest substantial upside potential if the bullish trend continues, with higher averages emerging in the 2030s and beyond. Risks include the inherent uncertainty of forward estimates and the possibility that actual results diverge from the projected path.
Tap a question to reveal the answer.
Avg $45.56, min $31.84, max $70.68; ROI 150.5%; sentiment BULLISH.
Forecasts show NEUTRAL in 2026 and BULLISH from 2027 onward, with rising averages (e.g., 2027 avg $26.11 and 2030 avg $45.56) and higher potential upside reflected in later years.
Yes. The 2035 max is $164.05 and the 2040 max is $241.41, with the 2040 average at $130.02, indicating the asset could surpass $100 in the forecast horizon.
Current price is $18.19 and market cap is $1.34B.
Sentiment BULLISH. RSI14 is 50, SMA50 is $17.42, SMA200 is $22.06. Support is $16.11, resistance is $18.84, and the 30-day range is $14.37 to $23.03. Annualized volatility is 70%.
MoonLake Immunotherapeutics Community Discussion
0Share your MoonLake Immunotherapeutics price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.